Increased placental sFlt-1 but unchanged PlGF expression in late-onset preeclampsia

References

• Lisonkova S, Joseph KS. Incidence of preeclampsia: Risk factors and outcomes associated with early- versus late-onset disease. Am J Obstet Gynecol 2013 Dec;209(6):544.e1–544.e12. doi:10.1016/j.ajog.2013.08.019.
   PubMed Web of Science ®Google Scholar
• Abalos E, Cuesta C, Carroli G, et al. Pre-eclampsia, eclampsia and adverse maternal and perinatal outcomes: A secondary analysis of the World Health Organization multicountry survey on maternal and newborn health. BJOG 2014 Mar;121(Suppl1):14–24.
   PubMed Web of Science ®Google Scholar
• American College of Obstetricians and Gynecologists. ACOG practice bulletin. Diagnosis and management of preeclampsia and eclampsia. Int J Gynecol Obstet 2002 Jan;99(33):159–67.
   Google Scholar
• Huppertz B, Schneider H. Implantationsstoerungen, Praeeklampsie und intrauterine Wachstumsrestriktion. Gynaekologe 2012; 45:514–9.
   Google Scholar
• James JL, Whitley GS, Cartwright JE. Pre-eclampsia: Fitting together the placental, immune and cardiovascular pieces. J Pathol 2010 Aug;221(4):363–78. doi:10.1002/path.2719.
   PubMed Web of Science ®Google Scholar
• Schneider H, Baumann M. Praeeklampsie, Pathogenese und Vorhersage. Gynaekologe 2013;46:193–8.
   Google Scholar
• Maynard SE, Min JY, Merchan J, et al. Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia. J Clin Invest 2003 Mar;111(5):649–58. doi:10.1172/JCI17189.
   PubMed Web of Science ®Google Scholar
• Rana S, Powe CE, Salahuddin S, et al. Angiogenic factors and the risk of adverse outcomes in women with suspected preeclampsia. Circulation 2012 Feb;125(7):911–9. doi:10.1161/CIRCULATIONAHA.111.054361.
   PubMed Web of Science ®Google Scholar
• Vrachnis N, Kalampokas E, Sifakis S, et al. Placental growth factor (PlGF): A key to optimizing fetal growth. J Matern Fetal Neonatal Med 2013 Jul;26(10):995–1002. doi:10.3109/14767058.2013.766694.
   PubMed Web of Science ®Google Scholar
• Ferrara N, Gerber HP, LeCouter J. The biology of VEGF and its receptors. Nat Med 2003 Jun;9(6):669–76. doi:10.1038/nm0603-669.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Stepan H, Dechend R. Angiogenic growth factors in the diagnosis and prediction of pre-eclampsia. Clin Sci (Lond) 2012 Jan;122(2):43–52. doi:10.1042/CS20110097.
   PubMed Web of Science ®Google Scholar
• Stepan H, Schaarschmidt W, Jank A, et al. Angiogene Faktoren zur Diagnosesicherung bei Praeeklampsie in der klinischen Routine: erste Erfahrungen. Z Geburtsh Neonatol 2010;214:234–8.
   PubMed Web of Science ®Google Scholar
• Verlohren S, Galindo A, Schlembach D, et al. An automated method for the determination of the sFlt-1/PIGF ratio in the assessment of preeclampsia. Am J Obstet Gynecol 2010 Feb;202(2):161.e1–161.e11. doi:10.1016/j.ajog.2009.09.016.
   PubMed Web of Science ®Google Scholar
• Herraiz I, Droege LA, Gómez-Montes E, et al. Characterization of the soluble fms-like tyrosine kinase-1 to placental growth factor ratio in pregnancies complicated by fetal growth restriction. Obstet Gynecol 2014 Aug; 124 (2 Pt 1): 265–73. doi:10.1097/AOG.0000000000000367.
   PubMed Web of Science ®Google Scholar
• Vatten LJ, Asvold BO, Eskild A. Angiogenic factors in maternal circulation and preeclampsia with or without fetal growth restriction. Acta Obstet Gynecol Scand 2012 Dec;91(12):1388–94. doi:10.1111/j.1600-0412.2012.01516.x.
   PubMed Web of Science ®Google Scholar
• Brown MA, Lindheimer MD, de Swiet M, et al. The classification and diagnosis of the hypertensive disorders of pregnancy: Statement from the International Society for the Study of Hypertension in Pregnancy (ISSHP). Hypertens Pregnancy 2001;20(1):IX–XIV. doi:10.1081/PRG-100104165.
   PubMed Web of Science ®Google Scholar
• Seely EW, Ecker J. Clinical practice. Chronic hypertension in pregnancy. N Engl J Med 2011 Aug;365(5):439–46. doi:10.1056/NEJMcp0804872.
   Google Scholar
• Nevo O, Many A, Xu J, et al. Placental expression of soluble fms-like tyrosine kinase 1 is increased in singletons and twin pregnancies with intrauterine growth restriction. J Clin Endocrinol Metab 2008 Jan;93(1):285–92. doi:10.1210/jc.2007-1042.
   PubMed Web of Science ®Google Scholar
• Tsatsaris V, Goffin F, Munaut C, et al. Overexpression of the soluble vascular endothelial growth factor receptor in preeclamptic patients: Pathophysiological consequences. J Clin Endocrinol Metab 2003 Nov;88(11):5555–63. doi:10.1210/jc.2003-030528.
   PubMed Web of Science ®Google Scholar
• Shibata E, Rajakumar A, Powers RW, et al. Soluble fms-like tyrosine kinase 1 is increased in preeclampsia but not in normotensive pregnancies with small-for-gestational age neonates: Relationship to circulating placental growth factor. J Clin Endocrinol Metab 2005 Aug;90(8):4895–903. doi:10.1210/jc.2004-1955.
   PubMed Web of Science ®Google Scholar
• Rolfo A, Giuffrida D, Nuzzo AM, et al. Pro-inflammatory profile of preeclamptic placental mesenchymal stromal cells: New insights into the etiopathogenesis of preeclampsia. PLoS One 2013;8(3):e59403. doi:10.1371/journal.pone.0059403.
   PubMed Web of Science ®Google Scholar
• Helske S, Vuorela P, Carpén O, et al. Expression of vascular endothelial growth factor receptors 1, 2 and 3 in placentas from normal and complicated pregnancies. Mol Hum Reprod. 2001 Feb;7(2):205–10.
   PubMed Web of Science ®Google Scholar
• Gu Y, Lewis DF, Wang Y. Placental productions and expressions of soluble endoglin, soluble fms-like tyrosine kinase receptor-1, and placental growth factor in normal and preeclamptic pregnancies. J Clin Endocrinol Metab 2008 Jan;93(1):260–6. doi:10.1210/jc.2007-1550.
   PubMed Web of Science ®Google Scholar
• Rajakumar A, Cerdeira AS, Rana S, et al. Transcriptionally active syncytial aggregates in the maternal circulation may contribute to circulating soluble fms-like tyrosine kinase 1 in preeclampsia. Hypertension 2012 Feb;59(2):256–264. doi:10.1161/HYPERTENSIONAHA.111.182170.
   PubMed Web of Science ®Google Scholar
• Andraweera PH, Dekker GA, Laurence JA, Roberts CT. Placental expression of VEGF family mRNA in adverse pregnancy outcomes. Placenta 2012 Jun;33(6):467–72. doi:10.1016/j.placenta.2012.02.013.
   PubMed Web of Science ®Google Scholar
• Bersinger NA, Groome N, Muttukrishna S. Pregnancy-associated and placental proteins in the placental tissue of normal pregnant women and patients with pre-eclampsia at term. Eur J Endocrinol 2002 Dec;147(6):785–93.
   PubMed Web of Science ®Google Scholar
• Weed S, Bastek JA, Anton L, et al. Examining the correlation between placental and serum placenta growth factor in preeclampsia. Am J Obstet Gynecol 2012 Aug;207(2):140.e1–140.e6. doi:10.1016/j.ajog.2012.05.003.
   PubMed Web of Science ®Google Scholar